Medical and Pharmaceutical Industry - Market Research Report

  The global   mortuary equipment market   size was estimated at USD 1.11 billion in 2024 and is projected to reach USD 1.55 billion by 2030, expanding at a CAGR of 5.6% from 2025 to 2030. This growth is primarily driven by the rising death rates, which have resulted in a heightened demand for essential mortuary equipment such as body bags, refrigeration units, and autopsy tables. The increase in mortality rates has highlighted the urgent requirement for improved mortuary services and related equipment, thereby positioning the market for substantial expansion. According to the World Population Review 2023, the population of individuals aged 65 and above in Least Developed Countries (LDCs) is expected to grow at a significantly faster pace than in Other Developing Countries (ODCs). Between 2023 and 2050, the older adult population in LDCs is projected to nearly triple, while ODCs will experience more than a twofold increase in the same timeframe. This demographic shift is ...

  The global   military wearable medical devices market   size was estimated at USD 7.45 billion in 2023 and is projected to reach USD 38.77 billion by 2030, growing at a CAGR of 26.3% from 2024 to 2030. A key factor driving this market is the increasing investment in research and development of advanced military technologies focused on soldier safety and health monitoring. The market growth is further supported by the growing dependence on real-time physiological data collection, such as heart rate, blood pressure, oxygen saturation, and body temperature. These vital signs are critical for assessing a soldier's physical condition and ensuring immediate medical intervention during field missions. Rising global conflicts have escalated the demand for military wearable medical devices that enable health tracking for soldiers deployed in various terrains. These devices are typically compact, lightweight, and integrated with wireless cloud connectivity, reducing the physical ...

  The   Middle East & Africa (MEA) diabetes care devices market   was valued at USD 1.03 billion in 2023 and is anticipated to grow at a CAGR of 8.20% from 2024 to 2030. This growth is largely attributed to the increasing prevalence of diabetes across the region, influenced by evolving lifestyles and associated health issues. Diabetic patients must consistently monitor and manage their blood glucose levels, requiring routine use of insulin or carbohydrate intake adjustments. As diabetes becomes a mounting healthcare concern, the demand for effective diabetes management tools continues to grow. According to the International Diabetes Federation (IDF) MENA Region, in 2021, approximately 73 million people aged 20–79 were living with diabetes, a number expected to rise to 95 million by 2030. Additionally, 48 million individuals in the region had impaired glucose tolerance, increasing their risk of developing type 2 diabetes. Diabetes-related fatalities reached 796,000, an...

  The   U.S. interventional oncology market   size was estimated at USD 998.4 million in 2024 and is projected to reach USD 1,597 million by 2030, expanding at a CAGR of 8.17% from 2025 to 2030. This market growth is primarily driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive treatments, expanding investments in interventional oncology, and the aging population across the U.S. A major contributing factor is the rising incidence of cancer in the country. According to the American Cancer Society, approximately 2,041,910 new cancer cases are expected to be diagnosed in the U.S. in 2025, with 618,120 projected cancer-related deaths. As conventional therapies like chemotherapy and radiation often lead to significant side effects, minimally invasive techniques such as radiofrequency ablation and microwave ablation are becoming more popular. These procedures target tumors precisely while minimizing harm to surrounding tiss...

  The   U.S. AI in oncology market   size was valued at USD 890.5 million in 2023 and is projected to reach USD 5.9 billion by 2030, expanding at a CAGR of 28.25% from 2024 to 2030. This significant growth is driven by the rising prevalence of cancer, continuous advancements in AI-powered diagnostic tools, improvements in healthcare infrastructure, and a growing demand for early and precise cancer detection. In addition, the increasing focus by public and private entities on research and development is accelerating innovation in the field. For example, in October 2022, Vara secured USD 4.4 million in funding to launch an AI-enabled breast cancer screening platform aimed at millions of women. According to 2023 data from the National Institutes of Health (NIH), approximately 2.0 million individuals in the U.S. are diagnosed with cancer each year. Breast cancer emerged as the most common diagnosis, with 297,790 cases among women and 2,800 among men. Prostate cancer followed ...

  The global   HLA typing market   was valued at USD 1,032.1 million in 2022 and is anticipated to reach USD 1.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. This market growth is primarily driven by the increasing need for organ transplantation and the extensive application of human leukocyte antigen (HLA) testing in pharmacogenetics. HLA matching remains a critical method for evaluating tissue compatibility in transplantation. It is a mandatory procedure for all organ donors, whether the organs are from deceased individuals, relatives, or unrelated donors. Accurate HLA matching significantly reduces the risk of post-transplant complications. The demand for organ transplants has risen steadily over time. As reported by the Organ Procurement and Transplantation Network, 41,354 organ transplants were performed in the United States alone in 2021—a 5.9% increase compared to 2020. Kidney transplants were the most common, with 24,...

  The global   endoscope sterilization market   size was estimated at USD 1.20 billion in 2024 and is projected to reach USD 2.09 billion by 2030, expanding at a CAGR of 9.64% from 2025 to 2030. This growth is primarily driven by the rising volume of surgical procedures performed annually, which contributes to an increased risk of healthcare-associated infections (HAIs) related to endoscope usage. According to data published by ASP International GmbH, the FDA received 450 medical device reports between January 2017 and February 2021 concerning patient infections or contamination linked to urological endoscopes in the U.S., including three fatalities caused by subsequent bacterial infections. In response, Karl Storz temporarily recalled over 24 models of urological endoscopes and emphasized using sterilization procedures outlined in the Instructions for Use, as chemical disinfection alone was deemed inadequate. These lapses in effective disinfection are expected to drive t...

  With the continuously evolving pharmaceutical industry, one entity has silently emerged as a game changer for drug development and manufacturing: the Contract Development and Manufacturing Organization (CDMO) market. This versatile sector, which allows pharma players to outsource manufacturing and drug development, has successfully expedited the process of bringing life-saving therapies to patients. In other words, the pharmaceutical CDMO market is not just a support function but a catalyst that drives cost efficiencies and operational agility. Pharmaceutical companies are availing the services of CDMOs to leverage advanced API manufacturing, precision formulation delivery, and cutting-edge analytical development, which are important factors in making drug availability in markets faster while adhering to the highest quality and compliance standards. With projections showing robust growth and revenues exceeding USD 235.5 billion by 2030, the  pharmaceutical CDMO market  ...

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...

  The global   medical polymer market   is projected to reach USD 36.77 billion by 2030, growing at a CAGR of 8.0%, according to a recent report by Grand View Research, Inc. This growth is primarily attributed to the increasing adoption of polymers in medical implants due to their chemical inertness and excellent fatigue resistance. Furthermore, the growing demand for in-house and advanced medical devices is expected to boost the need for medical device packaging. High healthcare spending, especially in countries such as the U.S., China, and Germany, is anticipated to support the expansion of various application segments in the coming years. Additionally, the global rise in COVID-19 cases has increased the demand for medical devices, which in turn is fueling the medical polymer market. The raw materials used in medical polymer production include ethylene, propylene, caprolactam, corn starch, and silica stone (SiO2). Silica stone, a major element of the Earth's crust, is o...

  According to a recent study by Grand View Research, Inc., the global  small molecule CDMO (Contract Development and Manufacturing Organization) market  is projected to reach USD 108.46 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.1% from 2024 to 2030. Key factors driving this growth include the adoption of innovative technologies in small molecule drug development, the expansion of pharmaceutical pipelines focused on small molecule therapies, and the increasing reliance on CDMOs for their cost-efficiency and specialized services. Regulatory support for streamlined drug development and manufacturing processes, along with CDMOs scaling up their production capacities to meet growing industry needs, also contribute significantly to market expansion. For pharmaceutical companies, innovation and ease of access to clinical solutions remain essential. Specialty pharmaceutical firms and small-scale players are playing a pivotal role in meeting these cr...

  According to a recent report by Grand View Research, Inc., the global   hemodialysis and peritoneal dialysis market   is projected to reach USD 185.88 billion by 2030, expanding at a compound annual growth rate (CAGR) of 9.1% over the forecast period. This growth is driven by the rising incidence of renal diseases and a growing elderly population, both of which are increasing global demand for hemodialysis and peritoneal dialysis. Additionally, heightened investment in the development of innovative products is expected to create favorable market conditions. The COVID-19 pandemic significantly impacted the healthcare sector, leading to increased hospitalizations and the emergence of infection hotspots. During this period, the global need for Renal Replacement Therapy (RRT) rose, largely due to a higher prevalence of comorbidities such as Chronic Kidney Disease (CKD), diabetes, and hypertension. Consequently, the demand for dialysis machines surged. A study published by t...